3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
8
Sarcoma
1
Peripheral Nervous System Diseases
1
Neoplasm Metastasis
1
Breast Cancer Organoids
1
Interventions
eribulin
1
Lenalidomide
1
Amplified Fragment Length Polymorphism Analysis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Peripheral Nervous System Diseases
×
eribulin
×
Clear all
NCT03027245
2022-07-13
IRENE
Eisai Inc.
Completed
353 enrolled